- Home
- DTIL vs BRNS Comparison
DTIL vs BRNS Comparison
Compare DTIL & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- BRNS
- Stock Information
- Founded
- DTIL 2006
- BRNS 2016
- Country
- DTIL United States
- BRNS United Kingdom
- Employees
- DTIL N/A
- BRNS N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- DTIL Health Care
- BRNS Health Care
- Exchange
- DTIL Nasdaq
- BRNS Nasdaq
- Market Cap
- DTIL 44.1M
- BRNS 41.0M
- IPO Year
- DTIL 2019
- BRNS 2021
- Fundamental
- Price
- DTIL $4.96
- BRNS $1.04
- Analyst Decision
- DTIL Strong Buy
- BRNS Strong Buy
- Analyst Count
- DTIL 3
- BRNS 2
- Target Price
- DTIL $37.67
- BRNS $3.00
- AVG Volume (30 Days)
- DTIL 1.3M
- BRNS 46.0K
- Earning Date
- DTIL 11-04-2024
- BRNS 11-06-2024
- Dividend Yield
- DTIL N/A
- BRNS N/A
- EPS Growth
- DTIL N/A
- BRNS N/A
- EPS
- DTIL 1.45
- BRNS N/A
- Revenue
- DTIL $75,096,000.00
- BRNS $14,969,000.00
- Revenue This Year
- DTIL $52.95
- BRNS $1,805.74
- Revenue Next Year
- DTIL N/A
- BRNS N/A
- P/E Ratio
- DTIL $2.57
- BRNS N/A
- Revenue Growth
- DTIL 43.62
- BRNS 106.21
- 52 Week Low
- DTIL $3.61
- BRNS $0.80
- 52 Week High
- DTIL $19.43
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- DTIL 46.54
- BRNS 48.42
- Support Level
- DTIL $5.10
- BRNS $0.91
- Resistance Level
- DTIL $7.44
- BRNS $1.15
- Average True Range (ATR)
- DTIL 0.66
- BRNS 0.15
- MACD
- DTIL 0.14
- BRNS -0.01
- Stochastic Oscillator
- DTIL 35.25
- BRNS 34.96
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.